Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R.
ALNY Key Statistics
Stock Snapshot
As of today, Alnylam Pharmaceuticals(ALNY) shares are valued at $175.98. The company's market cap stands at 23.25B, with a P/E ratio of 39.24.
On 2026-10-30, Alnylam Pharmaceuticals(ALNY) stock traded between a low of $172.31 and a high of $242.00. Shares are currently priced at $175.98, which is +2.1% above the low and -27.3% below the high.
Alnylam Pharmaceuticals(ALNY) shares are trading with a volume of 11.8M, against a daily average of 2.55M.
In the last year, Alnylam Pharmaceuticals(ALNY) shares hit a 52-week high of $479.79 and a 52-week low of $172.31.
In the last year, Alnylam Pharmaceuticals(ALNY) shares hit a 52-week high of $479.79 and a 52-week low of $172.31.
ALNY News
Advertisement Why Alnylam Pharmaceuticals Stock Is Back in Focus Alnylam Pharmaceuticals (ALNY) just combined a big earnings surprise with fresh clinical data...
Analysts on Wall Street project that Alnylam Pharmaceuticals (ALNY Quick QuoteALNY - Free Report) will announce quarterly earnings of $2.19 per share in i...
Analyst ratings
70%
of 33 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.